SONM DNA X INC revenue, earnings and financials

For the quarter ended June 30, 2026, DNA X INC reported revenue of n/a, net income of −$1.25M and diluted EPS of −$0.92; for the fiscal year ended December 2025 revenue was n/a.

SONM annual revenue and earnings

• Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$5.41M, net income −$20.7M (margin n/a), EPS −$28.58
• Fiscal year ended Dec 2024: revenue $58.3M, gross profit $9.92M, operating income −$3.10M, net income −$33.6M (margin -57.7%), EPS −$128.37
• Fiscal year ended Dec 2023: revenue $93.6M, gross profit $19.3M, operating income $513K, net income −$90.0K (margin -0.1%), EPS −$0.02
• Fiscal year ended Dec 2022: revenue $69.8M, gross profit $11.6M, operating income −$14.3M, net income −$14.1M (margin -20.2%), EPS −$0.49
• Fiscal year ended Dec 2021: revenue $54.6M, gross profit $6.41M, operating income −$38.0M, net income −$38.6M (margin -70.8%), EPS −$4.08

SONM quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue n/a, net income −$1.25M, EPS −$0.92
• Quarter ended Mar 31, 2026: revenue n/a, net income $6.34M, EPS $5.01
• Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$8.89M, EPS −$11.01
• Quarter ended Sep 30, 2025: revenue $16.2M (up 7.9% year over year), net income −$4.75M, EPS −$4.83
• Quarter ended Jun 30, 2025: revenue $11.2M (down 2.8% year over year), net income −$7.48M, EPS −$14.15
• Quarter ended Mar 31, 2025: revenue $16.7M (down 0.3% year over year), net income $458K, EPS $1.41
• Quarter ended Dec 31, 2024 (from the annual report): revenue $15.0M (up 11.6% year over year), net income −$21.6M, EPS −$116.99
• Quarter ended Sep 30, 2024: revenue $15.0M (down 45.5% year over year), net income −$2.51M, EPS −$9.32
• Quarter ended Jun 30, 2024: revenue $11.5M (down 57.1% year over year), net income −$6.62M, EPS −$1.41
• Quarter ended Mar 31, 2024: revenue $16.8M (down 35.0% year over year), net income −$2.91M, EPS −$0.65
• Quarter ended Dec 31, 2023 (from the annual report): revenue $13.4M (down 44.3% year over year), net income −$1.35M, EPS −$0.26
• Quarter ended Sep 30, 2023: revenue $27.6M (up 34.5% year over year), net income $527K, EPS $0.12
• Quarter ended Jun 30, 2023: revenue $26.8M (up 124.5% year over year), net income $509K, EPS $0.11
• Quarter ended Mar 31, 2023: revenue $25.8M (up 94.6% year over year), net income $227K, EPS $0.01
• Quarter ended Dec 31, 2022 (from the annual report): revenue $24.1M (up 51.4% year over year), net income −$1.04M, EPS $0.15
• Quarter ended Sep 30, 2022: revenue $20.5M (up 41.9% year over year), net income −$1.61M, EPS −$0.04
• Quarter ended Jun 30, 2022: revenue $12.0M (up 0.0% year over year), net income −$4.23M, EPS −$0.22
• Quarter ended Mar 31, 2022: revenue $13.3M (up 8.3% year over year), net income −$7.21M, EPS −$0.38
• Quarter ended Dec 31, 2021 (from the annual report): revenue $15.9M, net income −$11.7M, EPS −$1.27
• Quarter ended Sep 30, 2021: revenue $14.4M, net income −$10.9M, EPS −$1.31

SONM cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$23.5M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$8.49M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$4.05M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$12.4M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$38.5M, share buybacks n/a

SONM balance sheet

• Jun 30, 2026: cash $900K, total assets $4.52M, total liabilities $5.75M, shareholders' equity −$1.23M
• Mar 31, 2026: cash $1.20M, total assets $4.84M, total liabilities $4.92M, shareholders' equity −$983K
• Dec 31, 2025: cash $1.30M, total assets $43.9M, total liabilities $50.6M, shareholders' equity −$7.96M
• Sep 30, 2025: cash $2.14M, total assets $40.2M, total liabilities $40.9M, shareholders' equity −$701K, long-term debt $250K
• Jun 30, 2025: cash $2.01M, total assets $36.1M, total liabilities $37.4M, shareholders' equity −$1.33M
• Mar 31, 2025: cash $2.12M, total assets $36.0M, total liabilities $37.0M, shareholders' equity −$1.08M, long-term debt $566K
• Dec 31, 2024: cash $5.34M, total assets $39.7M, total liabilities $45.4M, shareholders' equity −$5.70M
• Sep 30, 2024: cash $9.06M, total assets $49.1M, total liabilities $33.8M, shareholders' equity $15.3M

Is SONM profitable?

No. DNA X INC lost $8.55M over the last four quarters.

What is SONM's EPS?

Diluted earnings per share over the last four quarters were −$11.75; −$0.92 in the latest quarter.

SONM ownership and insider trades · All stocks